HighTower Advisors »

Gain Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 12k 1.77

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Gain Therapeutics

Jones Financial Companies, L.L
DME Capital Management
Vanguard Group
Citadel Advisors
Geode Capital Management
Cambridge Investment Research Advisors
Marshall Wace
UBS Group
Renaissance Technologies
BlackRock
State Street Corporation
Northern Trust
Susquehanna International
Morgan Stanley
Jane Street

View all funds holding Gain Therapeutics